Article
Pharmacogenetic Dosing of Warfarin in the Han-Chinese Population: A Randomized Trial
23 Jan 2017
Abstract excerpt
AIM: This study aimed to determine clinical utility of genotype-guided dosing for warfarin in Han-Chinese. METHODS: A total of 320 patients were randomly assigned International Warfarin Pharmacogenetic Consortium algorithm, Taiwan algorithm and optimal clinical care arms. The primary outcome of the study was the percentage of time in the therapeutic range during the first 90 days of treatment. RESULTS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
